NZK Market Update

MKTUPDTE
Wed, Dec 08 2021 08:33 am

8 December 2021

NZK - NEW ZEALAND KING SALMON – Earnings update

Further to context provided on 30 September 2021 as part of our FY22 half year results announcement (1H22: Feb to July 21), New Zealand King Salmon is now able to provide an update on full year earnings guidance.

The FY22 revised earnings forecast of proforma EBITDA is in the range of $10.5m to $12.5m, an increase from the previous guidance of $8.0m to $10.0m.

Although trading conditions remain challenging with elevated freight costs, inflationary pressure on raw materials and Covid restrictions impacting food services, we have seen a sustained gain in our financial performance. As previously noted, we continue to see an improvement in fish size, due to the change to our farming model.

The Consent hearing for our open ocean farming application, named “Blue Endeavour”, is nearing completion with the last day targeted for 21st December.

ENDS
Contacts
Grant Rosewarne, Managing Director and CEO, New Zealand King Salmon Investments Ltd email: [email protected]

Ben Rodgers, CFO, New Zealand King Salmon Investments Ltd email: [email protected]

Stephen Bayley, Company Secretary, New Zealand King Salmon Investments Ltd email: [email protected]






About New Zealand King Salmon New Zealand King Salmon is the world’s largest aquaculture producer of the premium King salmon species. We operate under our four key brands: Ōra King, Regal, Southern Ocean, and Omega Plus, as well as the New Zealand King Salmon label. We have been growing and selling salmon to consumers for more than 30 years. Today we employ around 500 people. New Zealand investors make up a significant percentage of the ownership of NZ King Salmon and the communities of Marlborough, Nelson Bays and Tasman are well represented, with around 400 of the 2,700 shareholders from Top of the South. More information can be found at www.kingsalmon.co.nz


Announcement PDF


Markets News

F&P Healthcare urges Govt to shut patent loophole
Markets

F&P Healthcare urges Govt to shut patent loophole

The company says the current patent loophole threatens its NZ operations.

Finance

‘Unusual’ volume of CCCFA changes in focus

Select committee mulls proposed changes to CCCFA, to report recommendations Oct 20.

‘Unusual’ volume of CCCFA changes in focus
Markets Market Close

NZX 50 dips despite Fletcher Building's 4.6% gain

Pacific Edge shares gained after it said it got a step closer to Medicare approval.

Gregor Thompson 15 Sep 2025
NZX 50 dips despite Fletcher Building's 4.6% gain